The Type VI secretion system (T6SS) is protein nanomachine which is widespread in Gram-negative 8 bacteria and used to translocate effector proteins directly into neighbouring cells. It represents a 9 versatile bacterial weapon which can deliver effectors into distinct classes of target cells, playing key 10 roles in inter-bacterial competition and bacterial interactions with eukaryotic cells. This versatility is 11 underpinned by the ability of the T6SS to deliver a vast array of effector proteins, with many distinct 12 activities and modes of interaction with the secretion machinery. Recent work has highlighted the 13 importance and diversity of interactions mediated by T6SSs within polymicrobial communities and 14 offered new molecular insights into effector delivery and action in target cells. 15
Introduction 20
The Type VI secretion system (T6SS) is a protein nanomachine deployed by many Gram-negative 21 bacteria in order to translocate effector proteins directly into target cells. Following its recognition 22 as the sixth major protein secretion system in Gram-negative bacteria (Mougous et al., 2006 ; 23 Pukatzki et al., 2006) , the T6SS was initially believed to function as a classical virulence factor, 24 namely to deliver effector proteins which destroy or manipulate the cells of eukaryotic host 25 organisms ('anti-eukaryotic T6SS'). However it has subsequently become clear that the primary 26 function of the T6SS is as a device for inter-bacterial competion. In other words, bacteria use the 27 T6SS to deliver toxic anti-bacterial effectors into rival bacterial cells ('anti-bacterial T6SS'). More 28 recently, the range of known uses of the T6SS has expanded further, including action against 29 microbial fungi and scavenging of scarce metal ions. In parallel, recent work has revealed the 30 whilst the widespread and well-characterised proteobacterial T6SS can be termed T6SS i . T6SS ii and 39
T6SS
iii have distinct components but a common overall mode of action when compared with the 40 canonical T6SS
i (Clemens et al., 2015; Russell et al., 2014) . A given bacterial species can contain 41 between one and six different T6SSs, with the complement of T6SSs present frequently varying 42 between individual strains. In some bacteria, one T6SS is used for two distinct roles, e.g. the T6SS in 43
Vibrio cholerae is both anti-bacterial and anti-eukaryotic (MacIntyre et al., 2010) , whilst in other 44 cases different T6SSs fulfil distinct roles, e.g. T6SS-5 and T6SS-1 in Burkholderia thailandensis have 45 exclusively anti-host and anti-bacterial activity, respectively (Schwarz et al., 2010) . In general, 46 different bacterial species and strains use and tailor their T6SS(s) for specific roles according to the 47 5 references therein). Other variations also exist, including PpkA-mediated phosphorylation of TssL in 120
A. tumefaciens (Lin et al., 2014) . 121
Modes of effector delivery 122
An important aspect of the versatility of the T6SS is its ability to deliver a large variety of different 123 types of effector proteins. To achieve this, effectors can associate with the expelled Hcp-VgrG-PAAR 124 structure through multiple distinct mechanisms in order to be translocated between cells (Figure 1 'evolved VgrGs') have been described, including VgrG-1 of V. cholerae, which possesses a C-terminal 136 actin crosslinking domain (ACD) (Pukatzki et al., 2007) . PAAR domain-containing specialised effectors 137 are also widespread and diverse, including many nuclease toxins. They can be based simply on a 138 PAAR domain followed by an effector domain, but also include a group of large polymorphic toxins 139 known as Rhs proteins. In the latter, a conserved central Rhs repeat domain is predicted to form a 140 shell-like structure around a C-terminal effector domain, with different Rhs proteins possessing a 141 multitude of distinct C-terminal domains and associated immunity proteins (Alcoforado Diniz & 142 Coulthurst, 2015; Hachani et al., 2014; Whitney et al., 2014; Zhang et al., 2012) . It also appears that 143 effector domains may on occasion be fused at the N-terminal end of PAAR proteins, further 144 emphasizing their modularity (Shneider et al., 2013) . A family of specialised Hcp effectors with a 145 number of distinct C-terminal effector domains, present in members of the Enterobacteriaceae, has 146 also recently been described (Ma et al., 2017a) . Thus all three components of the expelled 147 puncturing structure can be used for both cargo and specialised effector delivery modes. A given 148 T6SS is typically associated with multiple VgrG, PAAR and/or Hcp homologues, with or without 149 specialised effector domains, allowing for delivery of many effectors. Specific combinations of these 150 homologues define functional tube-spike units and determine the effectors translocated by that 151 firing event (Cianfanelli et al., 2016a 
Anti-bacterial effectors 174
T6SSs represent widespread and potent weapons for killing or inhibiting rival bacterial cells, both 175 within and between species. This is achieved by the delivery of broad-spectrum anti-bacterial 176 effectors (Figure 2) , with a given system typically able to deliver one or more representatives of 177 several different effector families. 178
Classes and modes of action of T6SS-delivered anti-bacterial effectors 179
A large number of T6SS effectors which target the peptidoglycan cell wall of recipient bacteria have 180 been identified. These peptidoglycan hydrolases can be divided into at least five families of 181 peptidoglycan amidases (Tae1-4, TaeX), which cleave specific bonds within the peptide cross-bridges 182 of the cell wall, and four families of peptidoglycan glycoside hydrolases (Tge1 given that many effectors identified to date still have no known or readily-predictable function and 211 that new effectors will be revealed by experimental and bioinformatic analysis of increasing 212 numbers of bacterial strains and species. 213
Self-protection by specific immunity proteins 214
Any bacterial cell possessing an anti-bacterial T6SS must possess a means to prevent self-intoxication 215 by its own effectors (cytoplasmic-acting effectors, prior to secretion) and intoxication by effectors 216 delivered into it by its neighbouring sibling cells (all effectors, incoming). This is achieved through 217 specific immunity proteins, which are encoded adjacent to the gene for the cognate effector protein. function. In addition to a typical, specific active site occlusion mechanism, it also has an enzymatic 225 ADP-ribosylhydrolase activity which removes the modification added by the effector and confers 226 broad resistance to related toxins (Ting et al., 2018) . 227
Evolution and acquisition of effector-immunity pairs 228
T6SS-mediated inter-bacterial competition occurs between and within bacterial species, mediated 229 by considerable variation in effector-immunity portfolio, even between strains of the same species. 230
In addition to diversity in the number and type of effector, there is also variation within effector 231 families, resulting in related but specific and mutually-incompatible effector-immunity pairs. In 232 general, effector-immunity pairs appear to be horizontally acquired in an inter-bacterial 'arms race'. 233
In the case of specialised effectors, there is some evidence, particularly for matrix. This scenario is likely to be conducive to T6SS-dependent interactions, and indeed T6SS 319 genes are frequently co-regulated with biofilm genes and the T6SS has been shown to allow 320 persistence of Burkholderia in a mixed biofilm (Schwarz et al., 2010) . On the other hand, it has been 321 suggested that extracellular polysaccharide may, in some cases, provide a physical barrier which 322 reduces the effectiveness of T6SS attacks (Toska et al., 2018) . 323
Social behaviour and acquisition of genetic material 324
Anti-bacterial T6SSs can represent a means by which one individual strain or genotype can 325 distinguish self from non-self (i.e. from closely related strains). In some cases, this manifests as the 326 formation of a boundary between two populations. In Proteus mirabilis, the formation of Dienes 327 lines, macroscopic boundaries between swarms of two non-identical strains, is dependent on T6SS- Ray et al., 2017) . In addition, a catalase effector from EHEC, KatN, was proposed to act against 388 reactive oxygen species within host cells (Wan et al., 2017) . 389
The T6SS as a weapon against eukaryotic microbial competitors 390 It is clear from the studies described in the previous section that the bacterial T6SS is able to deploy 391 effector proteins against eukaryotic cells, and it is also well-appreciated that many polymicrobial 392 communities, including those relevant clinically, contain both bacteria and fungi (Peleg et al., 2010) . Schematic illustration of the current model for the contraction-based 'firing' mechanism of the T6SS. The T6SS assembles with the contractile TssBC sheath in an 'extended' conformation. Contraction of this sheath, which is anchored to a cytoplasmic baseplate docked on an envelope-spanning membrane complex, drives the Hcp-VgrG-PAAR puncturing structure out of the cell. An adjacent target cell can also be breached by this tube-spike structure. Following contraction, TssH depolymerises the contracted sheath and the T6SS disassembles at least partially, ready for a new round of firing. The insets illustrate the different ways in which effectors can interact with the expelled Hcp-VgrG-PAAR puncturing structure in order to be translocated out of the secreting cell and into a target cell. 'Cargo' effectors non-covalently interact with Hcp, VgrG or PAAR proteins, whilst 'specialised' effectors consist of an effector domain covalently fused to a VgrG or Hcp protein or a protein containing a PAAR-repeat containing domain. For further details, see the text. Schematic illustration of modes of action of T6SS-delivered anti-bacterial effector proteins and their neutralisation by self-protecting immunity proteins. The T6SS can deliver a variety of toxic effector proteins into a target cell, which may act on different cellular targets including the peptidoglycan cell wall, cellular nucleic acids and the inner membrane. Immunity proteins specific for each individual effector are localised at the site of action of their cognate effector and typically neutralise the toxin by direct binding and physical inhibition. Immunity proteins protect the secreting cell from its own toxins prior to secretion, if they act in the cytoplasm and are not shielded by another structure such as an Rhs repeat domain (this possibility is not depicted here). Immunity proteins also protect genetically identical cells from the action of all the effectors delivered by their neighbouring sibling. Note that only one PAAR-containing protein and one VgrG trimer can be delivered in a single firing event, although several are included here for illustrative purposes. PG, peptidoglycan. albicans and S. cerevisiae. The action of Tfe1 leads to depolarisation of the fungal plasma membrane without formation of large aspecific pores. The action of Tfe2 disrupts inter-related pathways involved in sulfate assimilation, plasma membrane nutrient transport and amino acid metabolism, leading to a starvation response including induction of autophagy. Intoxication by Tfe1 and Tfe2 can eventually cause cell death (Trunk et al., 2018) . (c) B. thailandensis uses its T6SS-4 to translocate TseM to the extracellular milieu, where it binds Mn 2+ . TseM loaded with Mn 2+ interacts with the outer membrane TonB-dependent receptor MnoT, which is associated with a TonB-ExbD-ExbB complex, transferring Mn 2+ from TseM to MnoT and allowing its active import across the outer membrane. Either the SitABCD or MntH transporters may then be utilised to import Mn 2+ across the inner membrane (Si et al., 2017b) .
